Newvast (atorvastatin strontium pentahydrate)
/ Hanmi
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 03, 2026
SEsiR-ACS: Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome
(clinicaltrials.gov)
- P4 | N=294 | Not yet recruiting | Sponsor: Seoul National University Bundang Hospital
New P4 trial • Acute Coronary Syndrome • Cardiovascular
September 26, 2022
An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
(clinicaltrials.gov)
- P=N/A | N=1716 | Completed | Sponsor: Hanmi Pharmaceutical Company Limited
New trial • Dyslipidemia • Metabolic Disorders
1 to 2
Of
2
Go to page
1